BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20607809)

  • 1. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc.
    Sun Y; Tao J; Zhang GG; Yu L
    J Pharm Sci; 2010 Sep; 99(9):4023-31. PubMed ID: 20607809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA.
    Tao J; Sun Y; Zhang GG; Yu L
    Pharm Res; 2009 Apr; 26(4):855-64. PubMed ID: 19052850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
    Amharar Y; Curtin V; Gallagher KH; Healy AM
    Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Polymer Molecular Weight on Drug-Polymer Solubility: A Comparison between Experimentally Determined Solubility in PVP and Prediction Derived from Solubility in Monomer.
    Knopp MM; Olesen NE; Holm P; Langguth P; Holm R; Rades T
    J Pharm Sci; 2015 Sep; 104(9):2905-12. PubMed ID: 25740567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of PVP/VA copolymer composition on drug-polymer solubility.
    Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
    Eur J Pharm Sci; 2016 Mar; 85():10-7. PubMed ID: 26826280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Study of Different Methods for the Prediction of Drug-Polymer Solubility.
    Knopp MM; Tajber L; Tian Y; Olesen NE; Jones DS; Kozyra A; Löbmann K; Paluch K; Brennan CM; Holm R; Healy AM; Andrews GP; Rades T
    Mol Pharm; 2015 Sep; 12(9):3408-19. PubMed ID: 26214347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new method to determine drug-polymer solubility through enthalpy of melting and mixing.
    Meiland P; Larsen BS; Knopp MM; Tho I; Rades T
    Int J Pharm; 2022 Dec; 629():122391. PubMed ID: 36379397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two DSC-based methods to predict drug-polymer solubility.
    Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
    Int J Pharm; 2018 Apr; 540(1-2):98-105. PubMed ID: 29425764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Crystallization Temperature Methodology for Polymer Selection in Amorphous Solid Dispersions: Stability Perspective.
    Bhugra C; Telang C; Schwabe R; Zhong L
    Mol Pharm; 2016 Sep; 13(9):3326-33. PubMed ID: 27414755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
    Prasad D; Chauhan H; Atef E
    Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced Solid-State Oxidation Studies of Nifedipine-PVP Amorphous Solid Dispersion.
    Saraf I; Roskar R; Modhave D; Brunsteiner M; Karn A; Neshchadin D; Gescheidt G; Paudel A
    Mol Pharm; 2022 Feb; 19(2):568-583. PubMed ID: 35060741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to predict the equilibrium solubility of drugs in solid polymers near room temperature using thermal analysis.
    Bellantone RA; Patel P; Sandhu H; Choi DS; Singhal D; Chokshi H; Malick AW; Shah N
    J Pharm Sci; 2012 Dec; 101(12):4549-58. PubMed ID: 22987330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.